1 |
The effect of selected methoxy flavonoids on the in vitro efflux transport of rhodamine 123 using rat jejunum / Stanley Anthony DoddDodd, Stanley Anthony January 2005 (has links)
Many orally administered drugs must overcome several barriers before
reaching their target site. The first major obstacle to cross is the intestinal epithelium.
Although lipophilic compounds may readily diffuse across the apical plasma membrane,
their subsequent passage across the basolateral membrane and into blood is by no
means guaranteed. Efflux proteins located at the apical membrane, which include P-glycoprotein
(P-gp, MDR1) and Multidrug Resistance-associated Protein (MRP2), may
drive compounds from inside the cell back into the intestinal lumen, preventing their
absorption into the blood. Intestinal P-gp is localised to the villus tip enterocytes, i.e. the
main site of absorption for orally administered compounds and in close proximity to the
lumen. P-gp is therefore ideally positioned to limit the absorption of compounds by
driving efflux back into the lumen. Drugs may also be modified by intracellular phase I
and phase II metabolizing enzymes. This process may not only render the drug
ineffective, but it may also produce metabolites that are themselves substrates for P-gp
and/or MRP2. Drugs that reach the blood are then passed to the liver, where they are
subjected to further metabolism and biliary excretion, often by a similar system of ATP binding
cassette (ABC) transporters and enzymes to that present in the intestine. Thus
a synergistic relationship exists between intestinal drug metabolizing enzymes and
apical efflux transporters, a partnership that proves to be a critical determinant of oral
bioavailability. Aim: The aim of this study was to investigate the effect of selected
methoxy flavonoids (3-methoxyflavone, 5-methoxyflavone, 6-methoxyflavone and 7-
methoxyflavone) on the mean ratio of Rhodamine123 (Rho 123) transport across rat
intestine (jejunum) and to investigate structure activity relationships (SAR) of the
selected flavonoids with reference to inhibition of P-gp. Methods: 3-Methoxyflavone, 5-
methoxyflavone, 6-methoxyflavone and 7-methoxyflavone were evaluated at a
concentration of 10μM and 20μM as modulators of Rho 123 transport across rat
jejunum. The Sweetana-Grass diffusion cells were used to determine the transport of
Rho 123. Each modulator was studied bidirectionally with two cells measuring transport
in the apical to basolateral direction (AP/BL) and two cells measuring transport in the
basolateral to apical direction (BUAP). The rate of transport was expressed as the
apparent permeability coefficient (Papp)and the extent of active transport was expressed
by calculating the ratio of BUAP to AP/BL. Each modulators Papp ratio was then
compared with that of the control. Results: 3-Methoxyflavone decreased the Papp
ratio from 3.34 (control) to 1.66 (10μM) and 1.33 (20μM) and showed statistical
significant differences. 7-Methoxyflavone decreased the Papp ratio to 1.94 (10μM) and
1.55 (20μM) but only showed a statistical significant difference at 10μM. 5-
Methoxyflavone decreased the Papp ratio to 2.41 (10μM) and 1.71 (20μM) and 6-
methoxyflavone decreased the Papp to 3.03 (10μM) and 2.49 (20μM). Both 5- and 6-
methoxyflavone showed no statistical significant differences from the control. The
structure activity relationships with reference to P-gp inhibition clearly indicated that the
C3 and C7 positioning of the methoxy-group on the A ring played a major role in the
inhibition of Rho 123 transport. Conclusion: All the selected modulators showed
inhibition of Rho 123 transport across the jejunum. This should affect the bioavailability
of the substrates of P-gp and other active transporters. In summary, this study describe
the inhibitory interaction of selected flavonoids with P-gp. Structure activity relationships
were identified describing the inhibitory potency of the flavonoids based on methoxy
groups positioning. The inhibitory potency results were 3-methoxyflavone > 7-
methoxyflavone > 5-methoxyflavone> 6-methoxyflavone / Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2005.
|
2 |
The effect of selected methoxy flavonoids on the in vitro efflux transport of rhodamine 123 using rat jejunum / Stanley Anthony DoddDodd, Stanley Anthony January 2005 (has links)
Many orally administered drugs must overcome several barriers before
reaching their target site. The first major obstacle to cross is the intestinal epithelium.
Although lipophilic compounds may readily diffuse across the apical plasma membrane,
their subsequent passage across the basolateral membrane and into blood is by no
means guaranteed. Efflux proteins located at the apical membrane, which include P-glycoprotein
(P-gp, MDR1) and Multidrug Resistance-associated Protein (MRP2), may
drive compounds from inside the cell back into the intestinal lumen, preventing their
absorption into the blood. Intestinal P-gp is localised to the villus tip enterocytes, i.e. the
main site of absorption for orally administered compounds and in close proximity to the
lumen. P-gp is therefore ideally positioned to limit the absorption of compounds by
driving efflux back into the lumen. Drugs may also be modified by intracellular phase I
and phase II metabolizing enzymes. This process may not only render the drug
ineffective, but it may also produce metabolites that are themselves substrates for P-gp
and/or MRP2. Drugs that reach the blood are then passed to the liver, where they are
subjected to further metabolism and biliary excretion, often by a similar system of ATP binding
cassette (ABC) transporters and enzymes to that present in the intestine. Thus
a synergistic relationship exists between intestinal drug metabolizing enzymes and
apical efflux transporters, a partnership that proves to be a critical determinant of oral
bioavailability. Aim: The aim of this study was to investigate the effect of selected
methoxy flavonoids (3-methoxyflavone, 5-methoxyflavone, 6-methoxyflavone and 7-
methoxyflavone) on the mean ratio of Rhodamine123 (Rho 123) transport across rat
intestine (jejunum) and to investigate structure activity relationships (SAR) of the
selected flavonoids with reference to inhibition of P-gp. Methods: 3-Methoxyflavone, 5-
methoxyflavone, 6-methoxyflavone and 7-methoxyflavone were evaluated at a
concentration of 10μM and 20μM as modulators of Rho 123 transport across rat
jejunum. The Sweetana-Grass diffusion cells were used to determine the transport of
Rho 123. Each modulator was studied bidirectionally with two cells measuring transport
in the apical to basolateral direction (AP/BL) and two cells measuring transport in the
basolateral to apical direction (BUAP). The rate of transport was expressed as the
apparent permeability coefficient (Papp)and the extent of active transport was expressed
by calculating the ratio of BUAP to AP/BL. Each modulators Papp ratio was then
compared with that of the control. Results: 3-Methoxyflavone decreased the Papp
ratio from 3.34 (control) to 1.66 (10μM) and 1.33 (20μM) and showed statistical
significant differences. 7-Methoxyflavone decreased the Papp ratio to 1.94 (10μM) and
1.55 (20μM) but only showed a statistical significant difference at 10μM. 5-
Methoxyflavone decreased the Papp ratio to 2.41 (10μM) and 1.71 (20μM) and 6-
methoxyflavone decreased the Papp to 3.03 (10μM) and 2.49 (20μM). Both 5- and 6-
methoxyflavone showed no statistical significant differences from the control. The
structure activity relationships with reference to P-gp inhibition clearly indicated that the
C3 and C7 positioning of the methoxy-group on the A ring played a major role in the
inhibition of Rho 123 transport. Conclusion: All the selected modulators showed
inhibition of Rho 123 transport across the jejunum. This should affect the bioavailability
of the substrates of P-gp and other active transporters. In summary, this study describe
the inhibitory interaction of selected flavonoids with P-gp. Structure activity relationships
were identified describing the inhibitory potency of the flavonoids based on methoxy
groups positioning. The inhibitory potency results were 3-methoxyflavone > 7-
methoxyflavone > 5-methoxyflavone> 6-methoxyflavone / Thesis (M.Sc. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2005.
|
3 |
Increased Cytotoxicity of 3,5 Dihydroxy -7- Methoxyflavone in MIA PaCa-2 and Panc28 Pancreatic Cancer Cells When Used in Conjunction With Proliferative Compound 3,5 Dihydroxy-7-Methoxyflavanone Both Derived From Chromolaena Leivensis (Hieron)Whitted, C., Torrenegra, R., Méndez, G., Lejeune, T., Rodríguez, J., Tsui, H., Rodríguez, O., Street, S., Miller, G., Palau, V. 30 December 2016 (has links) (PDF)
Over 5000 flavonoids have been identified so far and many of these are known to have antineoplastic properties. The relationships between the targeting activities by these compounds on cancer cells and the specific features that determine their molecular structures are not completely elucidated. Here we report the differential cytotoxic effects of two unsubstituted ring B flavonoids that differ solely in the presence of a C2, C3 double bond in ring C, on human cancer cells of the lung (A549), pancreas (MIA PaCa-2, Panc28), colon (HCT 116, CaCo-2), Liver (HepG2), and breast (SKBr3). These compounds were extracted from Chromolaena leivensis (Hieron) a plant belonging to the genus Chromolaena reputed to have antitumor activities. 3, 5 dihydroxy-7-methoxyflavone induce apoptosis in cancer cells of the lung A549, pancreas MIA PaCa-2 and Panc28, and colon HCT116, but not on Caco-2; whereas 3,5 dihydroxy-7-methoxyflavanone display proliferative effects in A549, Panc 28, MIA PaCa, and HCT116 cells at low concentrations, and slight cytotoxicity only on CaCo-2, a cancer cell line with a higher differentiation status than other cells tested. At the concentrations studied (5-80µM) neither compound demonstrated activity against cancer cells of the liver (HepG2) or breast (SKBr3) as indicated by MTT cell viability assays. When used in combination with 3,5 dihydroxy-7-methoxyflavone in pancreatic cancer cells, the targeting preference of 3, 5 dihydroxy-7-methoxyflavanone is altered, and a significant increase in inhibition of cell viability is observed 48 hours after dosing. The presence or absence of the C2, C3 double bond in ring C, accounts for electrochemical and structural changes that dictate differential specificity towards cancer cells. 3,5 dihydroxy-7-methoxyflavone has a more planar structure, whereas the absence of the double bond in C2, C3 causes ring B to adopt a perpendicular orientation to the plane formed by rings A and C and the OH group at C3.
|
4 |
Methoxylated but not hydroxylated flavones elicit significant activity against Parp-1-mediated cell death (Parthanatos)Zhang, Jingwen, Marsh, J.R., Tait, A., Iqbal, M.M., Pritchard, C.J., Ma, A., Shang, Lijun, Fatokun, Amos A. 08 1900 (has links)
No / Flavonoids, of which flavones are a sub-group, are plant secondary metabolites found in a variety of natural food sources (e.g., vegetables) and wines. They elicit beneficial roles in health and disease through their antioxidant activity, but some of them have also now been found to exert specific effects on cell signalling.
We recently showed that methoxylation of the flavone structure at the 4ʹ position, or additionally at the 3ʹ position, to produce 4ʹ-methoxyflavone (4MF) and 3ʹ,4ʹ-dimethoxyflavone (DMF), respectively, significantly enhanced activity against the cell death (“parthanatos”) mediated by poly (ADP-ribose) polymerase (PARP). We report here our attempt to correlate the antioxidant and parthanatos-inhibitory activities of these methoxylated flavones with those of the hydroxylated flavonoids.
Cultures of HeLa and HaCaT cells were exposed to MNNG (50µM, up to 25min), which induces parthanatos, and the oxidant hydrogen peroxide (100µM – 2mM, up to 24h). The effects (up to 20µM) of the methoxylated flavones 4MF and DMF, the hydroxylated flavone luteolin (LN), and the non-flavone flavonoids quercetin (QE), naringin (NG) and epigallocatechin gallate (EGCG) on the reduction in viability (indicative of cell death) and morphological changes induced by MNNG or peroxide were then investigated. Both alamar blue and MTT assays were used to quantify viability.
MNNG induced significant reduction in cell viability, which was not affected by the pan-caspase inhibitor Z-VAD-fmk but significantly blocked by DPQ, a PARP-1 inhibitor, consistent with the biochemical profile of parthanatos. Hydrogen peroxide also elicited a significant decrease in cell viability, with partial or no protection afforded by either Z-VAD-fmk or DPQ (dependent on peroxide concentration and treatment duration). 4MF and DMF demonstrated significant protection against MNNG-induced cell death but LN, QE, NG and EGCG showed little or no protection. On the other hand, 4MF and DMF elicited mostly negligible effects against hydrogen peroxide, whereas LN, QE, NG and EGCG elicited various levels of protection against it.
We conclude that methoxylation at the 4ʹ or 3ʹ, 4ʹ positions of flavones favours anti-parthanatos but not antioxidant activity, whereas hydroxylation enhances antioxidant but not anti-parthanatos activity. / Abstract of conference paper.
|
Page generated in 0.0429 seconds